CSF2 and Sepsis: More importantly, high local concentrations of GM-CSF in the alveolar space are prerequisite for its beneficial effects [15] and systemic GM-CSF delivery (intravenous infusion) in patients with sepsis-induced lung injury failed to improve the outcome [16].